Volvo AB Series A (0MHW)
London Exchange · UK · prices in SEK · close of 20 Oct 2026
Key indicators
| Last close | SEK 320.00 |
|---|---|
| 52-week range | 255.00 – 374.60 |
| Return, 1 month / 3 months | −3.7% / −7.0% |
| Return, 1 year / 3 years | +23.4% / +52.8% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 24.2% |
| Worst drawdown (1 year) | -18.0% |
| Average daily value traded | 4.20M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Volvo Group is a Swedish manufacturer of commercial vehicles and equipment, based in Gothenburg. It builds heavy trucks and buses for haulage and passenger transport operators, and makes construction machinery such as excavators and wheel loaders for building and mining work. The group also supplies marine and industrial engines and offers financing, servicing and spare parts support to customers who run its vehicles and machines across many countries.
The shares are listed on the London Exchange in UK under the code 0MHW, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Volvo AB Series A (0MHW) trades on the London Exchange in UK. It last closed at SEK 320.00 on 20 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,283 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 23.4% and over the last three months it fell 7.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.8% | ||
| From 52-week high | -13.4% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.0% | ||
| 6-month return | -0.4% | ||
| 12-month return, skipping the last month | 28.1% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.0% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 4.20M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | +1.5% |
|---|---|
| 1 month | −3.7% |
| 3 months | −7.0% |
| 6 months | −0.4% |
| 1 year | +23.4% |
| 3 years | +52.8% |
| 5 years | +77.0% |
Signals
| 50-day / 200-day average | 333.33 / 329.07 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.68 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Apr 2025 | SEK 8.0000 |
| 28 Mar 2024 | SEK 7.5000 |
| 5 Apr 2023 | SEK 7.0000 |
| 7 Apr 2022 | SEK 6.5000 |
| 30 Jun 2021 | SEK 9.5000 |
| 1 Apr 2021 | SEK 6.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.